These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8567179)

  • 1. Stereochemical analysis of the antigenic tip of the V3 loop peptide of HIV-1 gp120.
    Gunasekaran K; Ramakrishnan C; Balaram P
    Int J Pept Protein Res; 1995 Nov; 46(5):359-65. PubMed ID: 8567179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs.
    Stanfield R; Cabezas E; Satterthwait A; Stura E; Profy A; Wilson I
    Structure; 1999 Feb; 7(2):131-42. PubMed ID: 10368281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.
    Andrianov AM; Veresov VG
    J Biomol Struct Dyn; 2007 Jun; 24(6):597-608. PubMed ID: 17508782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
    Andrianov AM; Anishchenko IV
    J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the principal neutralization site of HIV-1.
    Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
    Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements.
    Balbach JJ; Yang J; Weliky DP; Steinbach PJ; Tugarinov V; Anglister J; Tycko R
    J Biomol NMR; 2000 Apr; 16(4):313-27. PubMed ID: 10826883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
    Stanfield RL; Ghiara JB; Ollmann Saphire E; Profy AT; Wilson IA
    Virology; 2003 Oct; 315(1):159-73. PubMed ID: 14592768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the V3 loop of a Thailand HIV isolate.
    Gupta G; Anantharamaiah GM; Scott DR; Eldridge JH; Myers G
    J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].
    Andrianov AM
    Tsitologiia; 2006; 48(11):948-57. PubMed ID: 17233480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation affects both the three-dimensional structure and antibody binding properties of the HIV-1IIIB GP120 peptide RP135.
    Huang X; Barchi JJ; Lung FD; Roller PP; Nara PL; Muschik J; Garrity RR
    Biochemistry; 1997 Sep; 36(36):10846-56. PubMed ID: 9312273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
    J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single point mutation in HIV-1 V3 loop alters the immunogenic properties of rgp120.
    Lee SK; Pestano GA; Riley J; Hasan AS; Pezzano M; Samms M; Park KJ; Guyden J; Boto WM
    Arch Virol; 2000; 145(10):2087-103. PubMed ID: 11087093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of structurally conservative amino acids of the HIV-1 protein gp120 V3 loop as promising targets for drug design by protein engineering approaches.
    Andrianov AM; Veresov VG
    Biochemistry (Mosc); 2006 Aug; 71(8):906-14. PubMed ID: 16978155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational preferences of the HIV-1 principal neutralizing determinant.
    Andrianov AM
    J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and polymorphism of HIV-1 third variable loops.
    Catasti P; Bradbury EM; Gupta G
    J Biol Chem; 1996 Apr; 271(14):8236-42. PubMed ID: 8626517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen.
    Rini JM; Stanfield RL; Stura EA; Salinas PA; Profy AT; Wilson IA
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6325-9. PubMed ID: 8327513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.